Appendix is a priming site in the development of ulcerative colitis

World Journal of Gastroenterology

Volumn 11, Issue 31, 2005, Pages 4869-4874

  Matsushita, Mitsunobu ^a   Takakuwa, Hiroshi ^b   Matsubayashi, Yuji ^b   Nishio, Akiyoshi ^c   Ikehara, Susumu ^a   Okazaki, Kazuichi ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b TENRI HOSPITAL   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Activated T cell; Appendectomy; Appendix; CD4+ T cell; Ulcerative colitis

Indexed keywords

CD4 ANTIGEN; CD69 ANTIGEN; CD8 ANTIGEN; HLA DR ANTIGEN; MESALAZINE; PREDNISOLONE; SALAZOSULFAPYRIDINE;

ADOLESCENT; ADULT; AGED; APPENDIX DISEASE; ARTICLE; CELL ISOLATION; COLON BIOPSY; COLONOSCOPY; CONTROLLED STUDY; DISEASE ACTIVITY; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOGENESIS; LYMPHOCYTE COUNT; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; RECTUM BIOPSY; SCHOOL CHILD; SCORING SYSTEM; T LYMPHOCYTE ACTIVATION; TRANSVERSE COLON; ULCERATIVE COLITIS;

EID: 24044464503     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i31.4869     Document Type: Article

References (37)

1. Rachmilewitz D, Karmeli F, Takabayashi K, Hayashi T, Leider-Trejo L, Lee J, Leoni LM, Raz E. Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis. Gastroenterology 2002; 122: 1428-1441
2. Walker MR, Kasprowicz DJ, Gersuk VH, Be'nard A, Van Landeghen M, Buckner JH, Ziegler SF. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. J Clin Invest 2003; 112: 1437-1443
3. Hu D, Ikizawa K, Lu L, Sanchirico ME, Shinohara ML, Cantor H. Analysis of regulatory CD8 T cells in Qa-1-dedicient mice. Nat Med 2004; 5: 516-523
4. Panaccione R, Sandborn WJ. The appendix in ulcerative colitis: a not so innocent bystander. Gastroenterology 1999; 117: 272-273
5. Rutgeerts P, D'haens G, Hiele M, Geboes K, Vantrappen G. Appendectomy protects against ulcerative colitis. Gastroenterology 1994; 106: 1251-1253
6. Russel MG, Dorant E, Brummer RJM, Van De Kruus MA, Muris JW, Bergers JM, Goedhard J, Stockbrugger RW. Appendectomy and the risk of developing ulcerative colitis or Crohn's disease: results of a large case-control study. Gastroenterology 1997; 113: 377-382
7. Andersson RE, Olaison G, Tysk C, Ekbom A. Appendectomy and protection against ulcerative colitis. N Engl J Med 2001; 344: 808-814
8. Radford-Smith GL, Edwards JE, Purdie DM, Pandeya N, Watson M, Martin NG, Green A, Newman B, Florin THJ. Protective role of appendicectomy on onset and severity of ulcerative colitis and Crohn's disease. Gut 2002; 51: 808-813
9. Selby WS, Griffin S, Abraham N, Solomon MJ. Appendectomy protects against the development of ulcerative colitis but not affect its course. Am J Gastroenterol 2002; 97: 2834-2838
10. Cosnes J, Carbonnel F, Beaugerie L, Blain A, Reijasse D, Gendre JP. Effects of appendicectomy on the course of ulcerative colitis. Gut 2002; 51: 803-807
11. Naganuma M, Iizuka B, Torii A, Ogihara T, Kawamura Y, Ichinose M, Kojima Y, Hibi T. Appendectomy protects against the development of ulcerative colitis and reduces its recurrence: results of a multicenter case-controlled study in Japan. Am J Gastroenterol 2001; 96: 1123-1126
12. Mizoguchi A, Mizoguchi E, Chiba C, Bhan AK. Role of appendix in the development of inflammatory bowel disease in TCR-α mutant mice. J Exp Med 1996; 184: 707-715
13. Okazaki K, Onodera H, Watanabe N, Nakase H, Uose S, Matsushita M, Kawanami C, Imamura M, Chiba T. A patient with improvement of ulcerative colitis after appendectomy. Gastroenterology 2000; 119: 502-506
14. Muller S, Lory J, Corazza N, Griffiths GM, Z'Graggen K, Mazzucchelli L, Kappeler A, Mueller C. Activated CD4+ and CD8+ cytotoxic cells are present in increased numbers in the intestinal mucosa from patients with active inflammatory bowel disease. Am J Pathol 1998; 152: 261-268
15. Ueyama H, Kiyohara T, Sawada N, Isozaki K, Kitamura S, Kondo S, Miyagawa J, Kanayama S, Shinomura Y, Ishikawa H, Ohtani T, Nezu R, Nagata S, Matsuzawa Y. High Fas ligand expression on lymphocytes in lesions of ulcerative colitis. Gut 1998; 43: 48-55
16. Simpson SJ, Mizoguchi E, Allen D, Bhan AK, Terhorst C. Evidence that CD4+, but not CD8+ T cells are responsible for murine interleukin-2-dificient colitis. Eur J Immunol 1995; 25: 2618-2625
17. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998; 115: 182-205
18. Bhan AK, Mizoguchi E, Smith RN, Mizoguchi A. Colitis in transgenic and knockout animals as models of human inflammatory bowel disease. Immunol Rev 1999; 169: 195-207
19. Jo Y, Matsumoto T, Yada S, Nakamura S, Yao T, Hotokezaka M, Mibu R, Iida M. Histological and immunological features of appendix in patients with ulcerative colitis. Dig Dis Sci 2003; 48: 99-108
20. Schachter H, Kirsner JB. Definitions of inflammatory bowel disease of unknown etiology. Gastroenterology 1975; 68: 591-600
21. Riley SA, Mani V, Goodman MJ, Herd ME, Dutt S, Turnberg LA. Comparison of delayed-release 5-aminosalicylic acid (mesalazine) and sulfasalazine as maintenance treatment for patients with ulcerative colitis. Gastroenterology 1988; 94: 1383-1389
22. Meenan J, Spaans J, Grool TA, Pals ST, Tytgat GNJ, van Deventer SJH. Altered expression of α4β7, a gut homing integrin, by circulating and mucosal T cells in colonic mucosal inflammation. Gut 1997; 40: 241-246
23. Scott IS, Sheaff M, Coumbe A, Feakins RM, Rampton DS. Appendiceal inflammation in ulcerative colitis. Histopathology 1998; 33: 168-173
24. Kroft SH, Stryker SJ, Rao MS. Appendiceal involvement as a skip lesion in ulcerative colitis. Mod Pathol 1994; 7: 912-914
25. Haruta J, Kusugami K, Kuroiwa A, Ina K, Shinoda M, Morise K, Iokawa H, Morita M, Ishihara A, Sarai S. Phenotypic and functional analysis of lamina propria mononuclear cells from colonoscopic biopsy specimens in patients with ulcerative colitis. Am J Gastroenterol 1992; 87: 448-454
26. Sasakawa T, Takizawa H, Bannai H, Narisawa R, Asakura H. Activated CD4+ and CD8+ cells in the colonic mucosa of ulcerative colitis patients: their relationship to HLA-DR antigen expression on the colonic epithelium and serum soluble CD25 levels. Digestion 1995; 56: 516-522
27. Matsumoto T, Nakamura S, Shimizu M, Iida M. Significance of appendiceal involvement in patients with ulcerative colitis. Gastrointest Endosc 2002; 55: 180-185
28. Tibble JA, Sigthorsson G, Bridger S, Fagerhol MK, Bjarnason I. Surrogate marker of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology 2000; 119: 15-22
29. Bitton A, Peppercorn MA, Antonioli DA, Niles JL, Shah S, Bousvaros A, Ransil B, Wild G, Cohen A, Edwardes MD, Stevens AC. Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis. Gastroenterology 2001; 120: 13-20
30. Taurog JD, Richardson JA, Croft JT, Simmons WA, Zhou M, Ferna'ndez-Sueiro JL, Balish E, Hammer RE. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med 1994; 180: 2359-2364
31. Takahashi I, Kiyono H, Hamada S. CD4+ T-cell population mediates development of inflammatory bowel disease in T-cell receptor α chain-deficient mice. Gastroenterology 1997; 112: 1876-1886
32. Mizoguchi A, Mizoguchi E, Saubermann LJ, Higaki K, Blumberg RS, Bhan AK. Limited CD4 T-cell diversity associated with colitis in T-cell receptor α mutant mice requires a T helper 2 environment. Gastroenterology 2000; 119: 983-995
33. Probert CS, Chott A, Turner JR, Saubermann LJ, Stevens AC, Bodinaku K, Elson CO, Balk SP, Blumberg RS. Persistent clonal expansions of peripheral blood CD4+ lymphocytes in chronic inflammatory bowel disease. J Immunol 1996; 157: 3183-3191
34. Jarnerot G, Andersson M, Franze'n L. Laparoscopic appendectomy in patients with refractory ulcerative colitis. Gastroenterology 2001; 120: 1562-1563
35. Eri RD, Cross S, Misko I, Rickard M, Lumley J, Stitz R, Stevenson A, Lewindon P, Radford-Smith GL. Appendectomy for refractory ulcerative colitis: targeting the right patient. Gastroenterology 2002; 122: A61
36. Hallas J, Gaist D, Vach W, Sorensen HT. Appendicectomy has no beneficial effect on admission rates in patients with ulcerative colitis. Gut 2004; 53: 351-354
37. Hallas J, Gaist D, Vach W, Sorensen HT. The role of age in the protection of appendicectomy against ulcerative colitis: author's reply. Gut 2004; 53: 1719-1720